Skip to content

Community-based Approaches to Treating Hypertension and Colon Cancer Prevention

Community-based Approaches to Treating Hypertension and Colon Cancer Prevention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01092078
Acronym
MISTER-B
Enrollment
740
Registered
2010-03-24
Start date
2010-05-31
Completion date
2014-05-31
Last updated
2015-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Hypertension

Keywords

hypertension, colon cancer screening, african american, men, motivational interviewing, patient navigation

Brief summary

Black men constitute the demographic group with the greatest burden of premature death and disability from hypertension (HTN) in the United States. But while the disproportionately high rate of hypertension-related morbidity and mortality is well documented, the epidemic of colorectal cancer (CRC) among black men is comparatively under-appreciated. For example, CRC is a leading cause of cancer death in black men with a death rate 50% higher than in white men. Low rates of screening for CRC in this population contribute significantly to this problem. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of a lifestyle intervention delivered through telephone-based motivational interviewing (MINT) versus a patient navigation intervention on blood pressure reduction and CRC screening.

Interventions

BEHAVIORALMINT

Motivational interviewing for lifestyle changes associated with treating hypertension

BEHAVIORALPatient Navigation

Patient navigation for colonoscopy.

Sponsors

Cornell University
CollaboratorOTHER
Wayne State University
CollaboratorOTHER
NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Participants must be age 50 years or older, 2. Self-identify as a black or African American male, 3. Have uncontrolled hypertension as defined by systolic blood pressure (SBP) \> 135 mmHg or diastolic blood pressure (DBP) \> 85 mmHg and SBP \> 130 or DBP \> 80 mmHg (in those with diabetes at the screening).

Exclusion criteria

1\. Inability to comply with the study protocol (either self-selected or by indicating during screening that he could not complete all requested tasks).

Design outcomes

Primary

MeasureTime frameDescription
Blood PressureOutcome is measured at 6-month follow-upThree blood pressure measures and the average of the three measures will be obtained at baseline and 6-month follow-up using a Welch Allyn Vital Signs automated blood pressure monitor.
Colon Cancer Screening BehaviorThe outcome will be measured at 6-month follow-upWhether or not the participant was screened for colon cancer between baseline and 6-month follow-up will be assessed using self-report and patient medical records.

Secondary

MeasureTime frameDescription
Physical Activity6-month follow-upPhysical activity will be measured using the International Physical Activity Questionnaire (IPAQ).
Intrinsic Motivation to Exercise6-month Follow-upIntrinsic motivation will be assessed using a 17-item questionnaire.
Self-Efficacy (Exercise)6-month follow-upSelf-efficacy related to exercise will be measured using a 12-iten questionnaire.
Dietary Intake6-month follow-upDietary intake will be assessed using the Food Frequency Questionnaire.
Facilitators and Barriers to obtaining a colonoscopy6-month follow-upFacilitators and barriers to obtaining a colonoscopy will be assessed using a self-reported scale.
Self-efficacy (Diet)6-month follow-upSelf-efficacy relating to diet will be assessed using a 10-item scale.
Behavioral Intention relating to colon cancer screening6-month follow-upBehavioral intention to screen for colon cancer will be assessed using a self-reported scale.
Social Influence relating to colon cancer screening6-month follow-upSocial influence relating to colon cancer screening will be assessed using a self-reported questionnaire.
Intrinsic Motivation (Diet)6-month follow-upIntrinsic motivation relating to diet will be assessed using a 17-item scale.
Medication Adherence6-month follow-upMedication adherence will be assessed using the 4-item Morisky Medication Adherence scale.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026